NZ216325A - #w# 4,9 -11b-substituted steroids and pharmaceutical compositions - Google Patents

#w# 4,9 -11b-substituted steroids and pharmaceutical compositions

Info

Publication number
NZ216325A
NZ216325A NZ216325A NZ21632586A NZ216325A NZ 216325 A NZ216325 A NZ 216325A NZ 216325 A NZ216325 A NZ 216325A NZ 21632586 A NZ21632586 A NZ 21632586A NZ 216325 A NZ216325 A NZ 216325A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
substituted steroids
steroids
substituted
pharmaceutical
Prior art date
Application number
NZ216325A
Other languages
English (en)
Inventor
F Faustini
Alessio R D
V Villa
Salle E Di
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NZ216325A publication Critical patent/NZ216325A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ216325A 1985-05-31 1986-05-28 #w# 4,9 -11b-substituted steroids and pharmaceutical compositions NZ216325A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513723A GB8513723D0 (en) 1985-05-31 1985-05-31 11-beta substituted steroids

Publications (1)

Publication Number Publication Date
NZ216325A true NZ216325A (en) 1989-01-27

Family

ID=10579949

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ216325A NZ216325A (en) 1985-05-31 1986-05-28 #w# 4,9 -11b-substituted steroids and pharmaceutical compositions

Country Status (21)

Country Link
JP (1) JPS6212796A (xx)
KR (1) KR860009035A (xx)
AU (1) AU587031B2 (xx)
BE (1) BE904846A (xx)
CH (1) CH669385A5 (xx)
DE (1) DE3617883A1 (xx)
DK (1) DK251386A (xx)
ES (1) ES8707972A1 (xx)
FI (1) FI862278A (xx)
FR (1) FR2582654B1 (xx)
GB (2) GB8513723D0 (xx)
GR (1) GR861405B (xx)
HU (1) HU197925B (xx)
IL (1) IL78957A (xx)
IT (1) IT1190014B (xx)
NL (1) NL8601387A (xx)
NZ (1) NZ216325A (xx)
PT (1) PT82665B (xx)
SE (1) SE8602449L (xx)
SU (1) SU1508963A3 (xx)
ZA (1) ZA864065B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289073B1 (en) * 1987-04-24 1991-11-27 Akzo N.V. Novel 11-aryloestrane and 11-arylpregnane derivatives
ES2053714T3 (es) * 1987-12-12 1994-08-01 Akzo Nv Proceso para la preparacion de 11-arilesteroides.
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
DE19961219A1 (de) * 1999-12-15 2001-07-19 Jenapharm Gmbh 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH488682A (de) * 1965-07-30 1970-04-15 Ciba Geigy Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe
FR190F (xx) * 1965-10-22
FR5913M (xx) * 1965-12-02 1968-04-01
NL128375C (xx) * 1966-02-18
FR2054525B1 (xx) * 1969-07-28 1973-01-12 Roussel Uclaf
FR2054527B1 (xx) * 1969-07-28 1973-06-08 Roussel Uclaf
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
DE3617883A1 (de) 1986-12-04
SE8602449D0 (sv) 1986-05-29
FR2582654B1 (fr) 1988-06-03
IT8620598A1 (it) 1987-11-28
DK251386D0 (da) 1986-05-29
HU197925B (en) 1989-06-28
SU1508963A3 (ru) 1989-09-15
IT8620598A0 (it) 1986-05-28
ES8707972A1 (es) 1987-09-01
CH669385A5 (xx) 1989-03-15
BE904846A (fr) 1986-12-01
KR860009035A (ko) 1986-12-19
FI862278A0 (fi) 1986-05-29
ZA864065B (en) 1987-01-28
IT1190014B (it) 1988-02-10
DK251386A (da) 1986-12-01
HUT44575A (en) 1988-03-28
GR861405B (en) 1986-09-26
GB2175905A (en) 1986-12-10
SE8602449L (sv) 1986-12-01
GB8513723D0 (en) 1985-07-03
PT82665B (pt) 1988-08-17
GB2175905B (en) 1989-01-18
JPS6212796A (ja) 1987-01-21
IL78957A (en) 1990-11-29
PT82665A (en) 1986-06-01
AU587031B2 (en) 1989-08-03
AU5806286A (en) 1986-12-04
NL8601387A (nl) 1986-12-16
GB8612866D0 (en) 1986-07-02
FI862278A (fi) 1986-12-01
ES555298A0 (es) 1987-09-01
IL78957A0 (en) 1986-09-30
FR2582654A1 (fr) 1986-12-05

Similar Documents

Publication Publication Date Title
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ218089A (en) 7-piperazinyl, 4-oxoquinolines and pharmaceutical compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
NZ219776A (en) 11-substituted steroid 17, 2'-furan derivatives and pharmaceutical compositions
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ217123A (en) 7-alpha-cephalosporins, pharmaceutical compositions and intermediate compounds
NZ221189A (en) 1,4-benzodiazepines and pharmaceutical compositions
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
NZ216325A (en) #w# 4,9 -11b-substituted steroids and pharmaceutical compositions
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions